Nicolas Pineault
Overview
Explore the profile of Nicolas Pineault including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yousuf B, Pasha R, Pineault N, Ramirez-Arcos S
PLoS One
. 2024 Jul;
19(7):e0307920.
PMID: 39052660
Staphylococcus aureus is a well-documented bacterial contaminant in platelet concentrates (PCs), a blood component used to treat patients with platelet deficiencies. This bacterium can evade routine PC culture screening and...
2.
Manesia J, Maganti H, Almoflehi S, Jahan S, Hasan T, Pasha R, et al.
Cell Rep Methods
. 2023 Dec;
3(12):100663.
PMID: 38070507
Small molecules have enabled expansion of hematopoietic stem and progenitor cells (HSPCs), but limited knowledge is available on whether these agonists can act synergistically. In this work, we identify a...
3.
Tran A, Yan M, Branch D, Blacquiere M, Pineault N, Pasha R, et al.
Transfusion
. 2023 Feb;
63(4):877-882.
PMID: 36727643
Background: The Jr blood group system includes a single, high-prevalence antigen, Jr , encoded by the ABCG2 gene. The impact of anti-Jr in pregnancy is variable, ranging from no clinical...
4.
Saiyin T, Kirkham A, Bailey A, Shorr R, Pineault N, Maganti H, et al.
Transplant Cell Ther
. 2022 Nov;
29(2):129.e1-129.e9.
PMID: 36396108
Greater use of umbilical cord blood (UCB) for hematopoietic cell transplantation (HCT) is limited by the number of cells in banked units. Ex vivo culture strategies have been increasingly evaluated...
5.
Yousuf B, Pasha R, Pineault N, Ramirez-Arcos S
Vox Sang
. 2022 Sep;
117(11):1318-1322.
PMID: 36102149
Background And Objectives: Platelet concentrates (PCs) contaminated with Staphylococcus aureus can escape detection during PC screening, causing septic transfusion reactions. This study aimed to determine the impact of S. aureus...
6.
Howell A, Letcher B, Murphy K, Elmoazzen H, Petraszko T, Acker J, et al.
Transfusion
. 2022 Jul;
62(9):1818-1828.
PMID: 35851676
Background: Collection of HPC by apheresis (HPC-A) can sometimes result in higher collection volumes, increasing the dimethyl sulfoxide (DMSO) volume infused into patients and the space requirements in liquid nitrogen...
7.
Trepanier P, Fournier D, Simard C, Fontaine M, Stroncek D, Takanashi M, et al.
Transfusion
. 2022 Jun;
62(8):1595-1601.
PMID: 35770742
Background: The IL-3-pSTAT5 assay, a new, rapid, and standardized flow-cytometry-based assay may compensate for several limitations of the colony-forming unit (CFU) assay typically used for stem cell potency assessments of...
8.
Simard C, Fournier D, Pineault N, Trepanier P
Cytotherapy
. 2022 Apr;
24(9):879-883.
PMID: 35400594
Background Aims: The current gold standard for stem cell product potency assessment, the colony-forming unit (CFU) assay, delivers results that are difficult to standardize and requires a substantial amount of...
9.
Maganti H, Kirkham A, Bailey A, Shorr R, Kekre N, Pineault N, et al.
Cytotherapy
. 2022 Jan;
24(4):405-412.
PMID: 35039239
Background: Chimeric antigen-receptor T (CAR-T) cells represent great promise in cancer treatment. CRISPR/Cas9 gene editing in preclinical studies has enabled the development of enhanced CAR-T products with improved function and...
10.
Kaushal R, Jahan S, McGregor C, Pineault N
Cytotherapy
. 2021 Oct;
24(3):272-281.
PMID: 34654640
Background Aims: The use of effective methods for the cryopreservation of hematopoietic stem cells (HSCs) is vital to retain the maximum engraftment activity of cord blood units (CBUs). Current protocols...